Stevanato Group S.p.A. (STVN) Financial Ratios
7 years of historical data (2019–2025) · Healthcare · Medical - Instruments & Supplies
EV/EBITDA
↓
16.87
↓-29% vs avg
5yr avg: 23.93
30Y Low18.4·High27.1
P/FCF
↓
195.17
↓-29% vs avg
5yr avg: 275.51
P/B Ratio
↓
2.82
↓-46% vs avg
5yr avg: 5.23
30Y Low3.7·High7.1
ROE
↓
9.3%
↑-35% vs avg
5yr avg: 14.2%
30Y Low9%·High27%
Debt/EBITDA
↑
1.76
↑+27% vs avg
5yr avg: 1.38
30Y Low0.8·High3.5
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
STVN Valuation Multiples
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
Stevanato Group S.p.A. trades at 31.3x earnings, 28% below its 5-year average of 43.5x, sitting at the 0th percentile of its historical range. Compared to the Healthcare sector median P/E of 22.1x, the stock trades at a premium of 41%. On a free-cash-flow basis, the stock trades at 195.2x P/FCF, 29% below the 5-year average of 275.5x.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Market Cap | $4.8B | $5.5B | $5.9B | $7.2B | $4.8B | $5.9B | — | — |
| Enterprise Value | $5.2B | $5.8B | $6.3B | $7.6B | $4.7B | $5.8B | — | — |
| P/E Ratio → | 31.28 | 41.06 | 50.67 | 49.62 | 33.91 | 42.36 | — | — |
| P/S Ratio | 3.67 | 4.82 | 5.39 | 6.66 | 4.84 | 7.04 | — | — |
| P/B Ratio | 2.82 | 3.70 | 4.23 | 6.38 | 4.78 | 7.06 | — | — |
| P/FCF | 195.17 | 256.19 | — | — | — | 294.83 | — | — |
| P/OCF | 15.23 | 19.99 | 38.17 | 68.73 | 46.04 | 44.57 | — | — |
P/E links to full P/E history page with 30-year chart
STVN EV Ratios
Enterprise-value multiples — capital-structure-neutral measures of total business value
Stevanato Group S.p.A.'s enterprise value stands at 16.9x EBITDA, 29% below its 5-year average of 23.9x. The Healthcare sector median is 14.2x, placing the stock at a 19% premium on an enterprise-value basis.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 5.12 | 5.69 | 6.96 | 4.83 | 6.84 | — | — |
| EV / EBITDA | 16.87 | 21.75 | 25.96 | 27.07 | 18.45 | 26.42 | — | — |
| EV / EBIT | 24.71 | 31.86 | 37.55 | 38.99 | 24.77 | 33.87 | — | — |
| EV / FCF | — | 272.06 | — | — | — | 286.55 | — | — |
STVN Profitability
Margins and return-on-capital ratios measuring operating efficiency
Stevanato Group S.p.A. earns an operating margin of 16.1%. Operating margins have compressed from 18.5% to 16.1% over the past 3 years, signaling potential cost pressures or competitive headwinds. ROE of 9.3% is modest. ROIC of 7.7% represents adequate returns on invested capital.
Margins
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 29.0% | 29.0% | 27.4% | 31.3% | 32.5% | 31.4% | 29.3% | 25.7% |
| Operating Margin | 16.1% | 16.1% | 14.6% | 18.5% | 19.6% | 19.2% | 15.6% | 11.6% |
| Net Profit Margin | 11.8% | 11.8% | 10.7% | 13.4% | 14.5% | 15.9% | 11.9% | 7.3% |
Return on Capital
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| ROE | 9.3% | 9.3% | 9.3% | 13.7% | 15.5% | 23.3% | 27.3% | 14.8% |
| ROA | 5.5% | 5.5% | 5.4% | 7.8% | 9.3% | 11.3% | 8.5% | 4.4% |
| ROIC | 7.7% | 7.7% | 7.6% | 12.3% | 17.4% | 19.7% | 13.9% | 8.4% |
| ROCE | 9.5% | 9.5% | 9.6% | 14.9% | 16.9% | 18.7% | 16.2% | 10.0% |
STVN Leverage & Debt
Solvency and debt-coverage ratios — lower is generally safer
Stevanato Group S.p.A. carries a Debt/EBITDA ratio of 1.8x, which is manageable (45% below the sector average of 3.2x). Net debt stands at $340M ($471M total debt minus $131M cash). Interest coverage of 8.4x is adequate, though a cyclical earnings downturn could tighten the margin of safety.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.32 | 0.32 | 0.31 | 0.35 | 0.22 | 0.29 | 1.17 | 1.42 |
| Debt / EBITDA | 1.76 | 1.76 | 1.77 | 1.42 | 0.85 | 1.12 | 2.31 | 3.46 |
| Net Debt / Equity | — | 0.23 | 0.24 | 0.29 | -0.01 | -0.20 | 0.80 | 1.09 |
| Net Debt / EBITDA | 1.27 | 1.27 | 1.37 | 1.17 | -0.04 | -0.76 | 1.57 | 2.68 |
| Debt / FCF | — | 15.87 | — | — | — | -8.27 | 4.15 | — |
| Interest Coverage | 8.40 | 8.40 | 24.35 | 44.93 | 48.67 | 35.01 | 15.06 | 11.38 |
STVN Liquidity & Efficiency
Short-term solvency ratios and asset-utilisation metrics
A current ratio of 1.74x means Stevanato Group S.p.A. can comfortably meet its short-term obligations, though there is limited excess liquidity. The quick ratio of 1.24x is notably lower than the current ratio, indicating a significant portion of current assets is tied up in inventory. The current ratio has improved from 1.50x to 1.74x over the past 3 years.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.74 | 1.74 | 1.84 | 1.50 | 1.83 | 2.56 | 1.56 | 1.71 |
| Quick Ratio | 1.24 | 1.24 | 1.33 | 1.06 | 1.37 | 2.12 | 1.12 | 1.21 |
| Cash Ratio | 0.25 | 0.25 | 0.21 | 0.12 | 0.55 | 1.29 | 0.50 | 0.48 |
| Asset Turnover | — | 0.45 | 0.47 | 0.52 | 0.59 | 0.59 | 0.68 | 0.61 |
| Inventory Turnover | 3.02 | 3.02 | 3.27 | 2.92 | 3.11 | 3.88 | 3.36 | 3.02 |
| Days Sales Outstanding | — | 173.67 | 175.18 | 175.71 | 137.10 | 120.42 | 92.21 | 109.24 |
STVN Shareholder Yields
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Stevanato Group S.p.A. returns 0.3% to shareholders annually primarily through dividends. The payout ratio of 10.5% is conservative, leaving significant room for dividend growth or reinvestment. The earnings yield of 3.2% (inverse of P/E) provides a useful comparison to bond yields when assessing the stock's relative attractiveness to fixed income.
Dividends
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Dividend Yield | 0.3% | 0.3% | 0.2% | 0.2% | 0.3% | 0.2% | — | — |
| Payout Ratio | 10.5% | 10.5% | 12.3% | 9.8% | 9.5% | 8.3% | 11.3% | 15.7% |
Total Shareholder Return Metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Earnings Yield | 3.2% | 2.4% | 2.0% | 2.0% | 2.9% | 2.4% | — | — |
| FCF Yield | 0.5% | 0.4% | — | — | — | 0.3% | — | — |
| Buyback Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — | — |
| Total Shareholder Yield | 0.3% | 0.3% | 0.2% | 0.2% | 0.3% | 0.2% | — | — |
| Shares Outstanding | — | $273M | $273M | $265M | $265M | $265M | $265M | $265M |
Peer Comparison
Compare STVN with 10 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
 STVNYou | $5B | 31.3 | 16.9 | 195.2 | 29.0% | 16.1% | 9.3% | 7.7% | 1.8 |
 APOG | $888M | 16.4 | 24.1 | 9.3 | 22.7% | 6.0% | 10.8% | 8.1% | 6.1 |
 BCPC | $5B | 34.9 | 20.6 | 30.7 | 35.7% | 21.1% | 12.9% | 12.2% | 0.7 |
 BDX | $52B | 24.7 | 14.0 | 19.5 | 45.4% | 11.8% | 6.5% | 4.3% | 3.8 |
 WST | $24B | 48.2 | 31.4 | 50.4 | 35.9% | 20.1% | 16.9% | 17.5% | 0.6 |
 GTLS | $10B | 630.3 | 14.4 | 49.1 | 29.2% | 15.2% | 1.3% | 7.4% | 4.0 |
 AVTR | $7B | -12.3 | 61.7 | 13.2 | 32.7% | -3.8% | -9.2% | -2.0% | 24.1 |
 AZTA | $1B | -19.1 | 18.1 | 28.0 | 45.5% | -1.9% | -3.2% | -0.5% | 2.2 |
 PFE | $143B | 18.5 | 10.3 | 15.8 | 70.3% | 24.7% | 8.9% | 7.5% | 3.3 |
 LLY | $1.0T | 47.8 | 34.3 | 115.6 | 83.8% | 45.6% | 101.2% | 41.8% | 1.4 |
 NVO | $192B | 12.2 | 9.1 | 43.2 | 81.0% | 41.3% | 60.7% | 36.2% | 0.9 |
| Healthcare Median | — | 22.1 | 14.2 | 18.5 | 63.9% | -4.3% | -32.6% | -11.6% | 3.2 |
Peer selection based on competitive and market overlap. Compare multiple stocks →
Download Financial Ratios Data
Includes 30+ ratios · 7 years · Updated daily
Consensus-Based Analysis Tools
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Check Valuation
Historical Returns
10-year return with dividends reinvested.
Calculate
DCA Calculator
See how regular investing compounds over time.
Run Numbers
Peer Comparison
Compare growth, multiples, and margins vs sector.
Compare
STVN — Frequently Asked Questions
Quick answers to the most common questions about buying STVN stock.
What is Stevanato Group S.p.A.'s P/E ratio?
Stevanato Group S.p.A.'s current P/E ratio is 31.3x. The historical average is 43.5x.
What is Stevanato Group S.p.A.'s EV/EBITDA?
Stevanato Group S.p.A.'s current EV/EBITDA is 16.9x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 23.9x.
What is Stevanato Group S.p.A.'s ROE?
Stevanato Group S.p.A.'s return on equity (ROE) is 9.3%. The historical average is 16.2%.
Is STVN stock overvalued?
Based on historical data, Stevanato Group S.p.A. is trading at a P/E of 31.3x. Compare with industry peers and growth rates for a complete picture.
What is Stevanato Group S.p.A.'s dividend yield?
Stevanato Group S.p.A.'s current dividend yield is 0.34% with a payout ratio of 10.5%.
What are Stevanato Group S.p.A.'s profit margins?
Stevanato Group S.p.A. has 29.0% gross margin and 16.1% operating margin. Operating margin between 10-20% is typical for established companies.
How much debt does Stevanato Group S.p.A. have?
Stevanato Group S.p.A.'s Debt/EBITDA ratio is 1.8x, indicating moderate leverage. A ratio below 2x is generally considered financially healthy.